SCHEMBL3133076

SCHEMBL3133076

CCOC(=O)c1sc(C(F)(F)F)c(C#N)c1N

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.55
RXFP1 Q9HBX9 1/20 0.45
ALDH1A1 P00352 8/20 0.44
HPGD P15428 5/20 0.44
KDM4E B2RXH2 4/20 0.44
APOBEC3G Q9HC16 1/20 0.43
ADORA2A P29274 1/20 0.43
GLA P06280 2/20 0.42
GAA P10253 2/20 0.42
HSD17B10 Q99714 2/20 0.42
TSHR P16473 1/20 0.42
FNTA P49354 2/20 0.41
FNTB P49356 2/20 0.41
MAPT P10636 3/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
BRCA1 P38398 1/20 0.41
GRIA2 P42262 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3125293 0.85 L3MBTL1 (0.50) L3MBTL1RXFP1ALDH1A1HPGDKDM4E
SCHEMBL623479 0.81 L3MBTL1 (0.70) L3MBTL1RXFP1ALDH1A1HPGDKDM4E
SCHEMBL3135234 0.81 L3MBTL1 (0.58) L3MBTL1RXFP1ALDH1A1HPGDKDM4E
SCHEMBL3128683 0.79 L3MBTL1 (0.56) L3MBTL1RXFP1ALDH1A1HPGDKDM4E
SCHEMBL3139470 0.77 L3MBTL1 (0.53) L3MBTL1RXFP1ALDH1A1HPGDKDM4E
SCHEMBL623739 0.77 L3MBTL1 (0.53) L3MBTL1RXFP1ALDH1A1HPGDKDM4E
SCHEMBL3138042 0.76 GRIA4 (0.71) ALDH1A1HPGDKDM4EFNTAFNTB
SCHEMBL9865456 0.76 L3MBTL1 (0.55) L3MBTL1RXFP1ALDH1A1HPGDKDM4E
SCHEMBL9865266 0.75 L3MBTL1 (0.51) L3MBTL1RXFP1ALDH1A1HPGDKDM4E
SCHEMBL10379797 0.74 RXFP1 (0.49) L3MBTL1RXFP1ALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7642361-B2 Thiophene and furan compounds ELI LILLY AND COMPANY (US) 2010-01-05 US disclosed
US-7642361-B2 Thiophene and furan compounds ELI LILLY AND COMPANY (US) 2010-01-05 US disclosed
US-20070105852-A1 Thiophene and furan compounds ELI LILLY AND COMPANY 2007-05-10 US disclosed
US-20070105852-A1 Thiophene and furan compounds ELI LILLY AND COMPANY 2007-05-10 US disclosed
EP-1706395-A1 THIOPHENE AND FURAN COMPOUNDS ELI LILLY AND COMPANY (US) 2006-10-04 EP disclosed
WO-2005070916-A1 THIOPHENE AND FURAN COMPOUNDS ELI LILLY AND COMPANY (US) 2005-08-04 WO disclosed
WO-2005070916-A1 THIOPHENE AND FURAN COMPOUNDS ELI LILLY AND COMPANY (US) 2005-08-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070105852-A1 Thiophene and furan compounds PSEN2, PSEN1, TPMT L3MBTL1 3910/4885RXFP1 4836/4885ALDH1A1 1344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.